[Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
D000284:Administration, Oral; D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D002262:Carboxy-Lyases
Gjennomføring av behandlingen og vurdering av behandlingsalternativer ved parkinsonisme.